These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2166475)

  • 21. Characterization of specific growth hormone binding sites in mouse fibroblasts.
    Murphy LJ; Vrhovsek E; Lazarus L
    Endocrinology; 1983 Aug; 113(2):750-7. PubMed ID: 6307651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specificity of covalently stabilized complexes of 125I-labeled human somatotropin and components of the lactogenic binding sites of rat liver.
    Caamaño CA; Fernandez HN; Paladini AC
    Biochem Biophys Res Commun; 1983 Aug; 115(1):29-37. PubMed ID: 6311206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of lactogenic receptors in female hamster liver due to the human growth hormone analog produced by plerocercoids of the tapeworm, Spirometra mansonoides.
    Phares CK; Booth BJ
    Endocrinology; 1986 Mar; 118(3):1102-9. PubMed ID: 3004894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversible modification of arginine residues in neocarzinostatin. Isolation of a biologically active 89-residue fragment from the tryptic hydrolysate.
    Samy TS; Kappen LS; Goldberg IH
    J Biol Chem; 1980 Apr; 255(8):3420-6. PubMed ID: 6444949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactogenic and somatogenic binding sites in intact and detergent-solubilized membrane preparations of female rat liver.
    Haldosén LA; Gustafsson JA
    Biochem J; 1988 Jun; 252(2):509-14. PubMed ID: 3415671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of the effect of acetylation of specific lysine residues in human growth hormone on its affinity for somatogenic receptors by an affinity selection technique.
    Teh LC; Chapman GE
    Biochem Biophys Res Commun; 1988 Jan; 150(1):391-8. PubMed ID: 3122756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human growth hormone deletion mutant (hGH44-191) binds with high affinity to lactogenic receptors but not to somatogenic receptors.
    Haro LS; Singh RN; Lewis UJ; Martinez AO; Galosy SS; Staten NR; Krivi GG
    Biochem Biophys Res Commun; 1996 May; 222(2):421-6. PubMed ID: 8670221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective modification of tryptophan-150 in ovine placental lactogen.
    Cymes GD; Iglesias MM; Wolfenstein-Todel C
    Comp Biochem Physiol B; 1993 Nov; 106(3):743-6. PubMed ID: 8281766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential solubilization of placental lactogen (PL)- and growth hormone-binding sites: further evidence for a unique PL receptor in fetal and maternal liver.
    Freemark M; Comer M; Korner G
    Endocrinology; 1988 Jun; 122(6):2771-9. PubMed ID: 3371262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivity of D-amino acid oxidase with 1,2-cyclohexanedione: evidence for one arginine in the substrate-binding site.
    Ferti C; Curti B; Simonetta MP; Ronchi S; Galliano M; Minchiotti L
    Eur J Biochem; 1981 Oct; 119(3):553-7. PubMed ID: 6118269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of hepatic lactogen receptor. Subcellular distribution and characterization of N-linked carbohydrate chains.
    Haldosén LA; Andersson G; Gustafsson JA
    Biochem J; 1989 Oct; 263(1):33-40. PubMed ID: 2557824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of concanavalin A with lactogenic receptors in isolated membranes.
    Bhattacharya A; Vonderhaar BK
    Arch Biochem Biophys; 1982 May; 215(2):425-32. PubMed ID: 6284049
    [No Abstract]   [Full Text] [Related]  

  • 33. Somatogenic and lactogenic activity of the recombinant 22 kDa isoform of human placental growth hormone.
    Igout A; Frankenne F; L'Hermite-Balériaux M; Martin A; Hennen G
    Growth Regul; 1995 Mar; 5(1):60-5. PubMed ID: 7749349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships between structure and function of lactogenic hormones.
    Chêne N; de la Llosa P; Charpigny G; Martal J
    Reprod Nutr Dev (1980); 1986; 26(2B):551-61. PubMed ID: 3014623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical modification of arginine residues of Notechis scutatus scutatus notexin.
    Chang LS; Wu PF; Liou JC; Chiang-Lin WH; Yang CC
    Toxicon; 2004 Oct; 44(5):491-7. PubMed ID: 15450923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probing the active site residues in aromatic donor oxidation in horseradish peroxidase: involvement of an arginine and a tyrosine residue in aromatic donor binding.
    Adak S; Mazumder A; Banerjee RK
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):985-91. PubMed ID: 8615798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding inhibition by monoclonal antibodies of ovine placental lactogen to growth hormone receptors in human liver.
    Chan JS; Nie ZR; Seidah NG; Chrétien M
    FEBS Lett; 1986 May; 201(1):168-72. PubMed ID: 3011504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Clostridium difficile toxin A and B by 1,2-cyclohexanedione modification of an arginine residue.
    Balfanz J; Rautenberg P
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1364-70. PubMed ID: 2610698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of prolactin and placental lactogen receptors in ewes during pregnancy and lactation.
    Emane MN; Delouis C; Kelly PA; Djiane J
    Endocrinology; 1986 Feb; 118(2):695-700. PubMed ID: 3002762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placental lactogen and growth hormone receptors in human fetal tissues: relationship to fetal plasma human placental lactogen concentrations and fetal growth.
    Hill DJ; Freemark M; Strain AJ; Handwerger S; Milner RD
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1283-90. PubMed ID: 3372688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.